Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMNB for Pain Reduction Following Wisdom Molar Extractions
NCT05335070Phase 2Recruiting
- Sponsor
- Rutgers University
- Start
- Sep 2022
- Primary completion
- Nov 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine, epinephrine in acute pain, sponsored by Rutgers University. Started Sep 2022; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrineepinephrine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05335070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335070.